
GC35716
c-Met inhibitor 1
Also known as 3-(2-methylindazol-5-yl)sulfanyl-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine
c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer
ChemicalCAS1357072-61-7MW362.41FormulaC17H14N8S
- CAS number
- 1357072-61-7
- Molecular weight
- 362.41
- Formula
- C17H14N8S
- Solubility
- DMSO: 20 mg/mL (55·19 mM)
- InChIKey
- JYXHZDNTBJUJNH-UHFFFAOYSA-N
- Catalogue number
- GC35716
- Brand
- GLPBIO
Computed properties PubChem CID 56650915 · XLogP 1.8 · TPSA 104 Ų · H-bond donors 0
- XLogP
- 1.8
- TPSA
- 104 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 26
SMILES CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=CN(N=C5C=C4)C)C=C2
Computed descriptors from PubChem (CID 56650915), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il